Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1 / FLT3 -ITD Genotypes in Patients with Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 8914–8916.

https://doi.org/10.1182/blood-2022-158686

Published: 2022

Journal Articles

LigandCD70.CAR As a Platform for Dual-Targeting CAR T Cells for Acute Myeloid Leukemia

Lauren Scherer, Candise Tat, Tim Sauer, Haruko Tashiro, Swati Naik, Mireya Paulina Velasquez, Stephen Gottschalk, Cliona M. Rooney, Malcolm K. Brenner, Bilal Omer

Blood (2022) 140 (Supplement 1): 7396–7397.

https://doi.org/10.1182/blood-2022-170503

Published: 2022

Journal Articles

A Phase I/II Clinical Trial of Piggybac -Modified GMR CAR-T Cell Therapy for CD116 Positive Relapsed/Refractory Myeloid Malignancies

Shoji Saito, Miyuki Tanaka, Aiko Hasegawa, Yoichi Inada, Hirokazu Morokawa, Yoko Usami, Shunsuke Kojima, Ryu Yanagisawa, Chinatsu Miyazawa, Keiko Ito, Hitoshi Sakai, Hideyuki Nakazawa, Haruko Tashiro, Shigeki Yagyu, Yozo Nakazawa

Blood (2021) 138 (Supplement 1): 4813.

https://doi.org/10.1182/blood-2021-149089

Published: 2021

Journal Articles

Mutated GM-CSF-Based CAR T-Cells Targeting CD116/CD131 Complexes Exhibit Enhanced Anti-Tumor Effects Against Acute Myeloid Leukemia

Shoji Saito, MD PhD, Aiko Hasegawa, PhD, Mika Nagai, Yoichi Inada, Hirokazu Morokawa, MD, Ikumi Nakashima, Daisuke Morita, MD, PhD, Yuichiro Ide, Kazuyuki Matsuda, PhD, Haruko Tashiro, MD, Shigeki Yagyu, MD PhD, Miyuki Tanaka, MD PhD, Yozo Nakazawa, MD PhD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-134395

Published: 2020

Journal Articles

Enhancing the Effect of CLL-1 CAR T Cells with Interleukin-15 for Treatment of Acute Myeloid Leukemia

Pinar Ataca Atilla, MD, Haruko Tashiro, MD PhD, Mary Kathryn McKenna, PhD, Madhuwanti Srinivasan, Brian Wesley Simons, Alexandra McLean Stevens, MD PhD, Michele Redell, MD PhD, Maksim Mamonkin, PhD, Malcolm K. Brenner, MD PhD, Erden Atilla, MD

Blood (2019) 134 (Supplement_1): 3912.

https://doi.org/10.1182/blood-2019-127953

Published: 2019

Journal Articles

Interleukin (IL)-1 Beta and IL-6 Activated Acute and Chronic Myelogenous Leukemia-Derived Myofibroblasts to Express Leukemia-Specific Transcripts

Takuji Matsuo, MD, Haruko Tashiro, MD PhD, Ritsu Sumiyoshi, MD, Tadashi Yamamoto, MD PhD, Kensuke Matsumoto, MD PhD, Jun Ooi, MD, Naoki Shirafuji, MD PhD

Blood (2018) 132 (Supplement 1): 5094.

https://doi.org/10.1182/blood-2018-99-117704

Published: 2018

Journal Articles

FLT3-ITD Mutation in MDS Patients Is Associated with Early Transformation to AML

Ritsu Sumiyoshi, MD, Haruko Tashiro, MD PhD, Takuji Matsuo, MD, Tadashi Yamamoto, MD PhD, Yoko Oka-Miura, MD PhD, Kensuke Matsumoto, MD PhD, Jun Ooi, MD, Naoki Shirafuji, MD PhD

Blood (2017) 130 (Supplement 1): 5307.

https://doi.org/10.1182/blood.V130.Suppl_1.5307.5307

Published: 2017

Journal Articles

Low High-Density Lipoprotein Cholesterol (HDL) Is a Significant Poor Prognostic Factor in Malignant Lymphoma

Takuji Matsuo, MD, Haruko Tashiro, MD PhD, Ritsu Sumiyoshi, MD, Tadashi Yamamoto, MD PhD, Yoko Oka-Miura, MD PhD, Kensuke Matsumoto, MD PhD, Jun Ooi, MD, Naoki Shirafuji, MD PhD

Blood (2017) 130 (Supplement 1): 5148.

https://doi.org/10.1182/blood.V130.Suppl_1.5148.5148

Published: 2017

Journal Articles

Chimeric Antigen Receptor (CAR) T Cell Therapy for CD7-Positive Acute Myeloid Leukemia

Diogo Gomes-Silva, Haruko Tashiro, MD PhD, Madhuwanti Srinivasan, Premal Lulla, MBBS, Malcolm K. Brenner, MD PhD, Maksim Mamonkin, PhD

Blood (2017) 130 (Supplement 1): 2642.

https://doi.org/10.1182/blood.V130.Suppl_1.2642.2642

Published: 2017

Journal Articles

CD7 CAR for the Treatment of Acute Myeloid and Lymphoid Leukemia

Diogo Silva, Haruko Tashiro, MD PhD, Madhuwanti Srinivasan, Malcolm K. Brenner, MD PhD, Maksim Mamonkin, PhD

Blood (2016) 128 (22): 4555.

https://doi.org/10.1182/blood.V128.22.4555.4555

Published: 2016

Journal Articles

A T-cell–directed chimeric antigen receptor for the selective treatment of T-cell malignancies

Maksim Mamonkin, Rayne H. Rouce, Haruko Tashiro, Malcolm K. Brenner

Blood (2015) 126 (8): 983–992.

https://doi.org/10.1182/blood-2015-02-629527

Published: 2015

Includes: Supplemental data

Journal Articles

T Cell Receptor Vbeta Repertoire Plays An Important Role In Graft-Versus-Leukemia Effect To Acute Lymphocytic Leukemia With TCF3-PBX1

Yoko Oka, MD, PhD, Ryosuke Shirasaki, MD, PhD, Takuji Matsuo, MD, Haruko Tashiro, MD, PhD, Jun Ooi, MD, Naoki Shirafuji, MD, PhD

Blood (2013) 122 (21): 5434.

https://doi.org/10.1182/blood.V122.21.5434.5434

Published: 2013

Journal Articles

Interleukin-1 Beta Promotes the Expression of Prox-1 and Vascular Endothelial Growth Factor Receptor Type-3 in Adult Human Dermal Fibroblasts

Matsuo Takuji, Ryosuke Shirasaki, MD, Haruko Tashiro, MD, PhD, Yoko Oka, MD, PhD, Tadashi Yamamoto, MD, Nobu Akiyama, MD, PhD, Kazuo Kawasugi, MD, PhD, Naoki Shirafuji, MD, PhD

Blood (2012) 120 (21): 4738.

https://doi.org/10.1182/blood.V120.21.4738.4738

Published: 2012

Journal Articles

CD56(+)CD146(+) Cells in Normal Human Bone Marrow-Stroma Proliferated to Form Tumors in severe Combined Immunodeficiency Mice

Ryosuke Shirasaki, MD, Haruko Tashiro, MD, Yoko Oka, MD, PhD, Tadashi Yamamoto, MD, Nobu Akiyama, MD, PhD, Kazuo Kawasugi, MD, PhD, Naoki Shirafuji, MD, PhD

Blood (2011) 118 (21): 1328.

https://doi.org/10.1182/blood.V118.21.1328.1328

Published: 2011

Journal Articles

Increased Levels of PTX3 in Human Plasma in Septic Patients with DIC

Kazuo Kawasugi, MD, PhD, Tadashi Yamamoto, MD, Ryosuke Shirasaki, MD, Haruko Tashiro, MD, PhD, Naoki Shirafuji, MD, PhD

Blood (2011) 118 (21): 4347.

https://doi.org/10.1182/blood.V118.21.4347.4347

Published: 2011

Journal Articles

Interleukin-1β Promotes the Expression of CD34 and Granulocyte Colony-Stimulating Factor-Receptor in Adult Dermal Fibroblasts

Haruko Tashiro, MD, Ryosuke Shirasaki, MD, Yoko Oka, MD, PhD, Tadashi Yamamoto, MD, Nobu Akiyama, MD, PhD, Kazuo Kawasugi, MD, PhD, Naoki Shirafuji, MD, PhD

Blood (2011) 118 (21): 4815.

https://doi.org/10.1182/blood.V118.21.4815.4815

Published: 2011

Journal Articles

Tcf3/Pbx1 Fusion Molecule Induces the Transcription of Prox-1 and Vascular Endothelial Growth Factor Receptor Type-3

Yoko Oka, MD, PhD, Ryosuke Shirasaki, MD, Haruko Tashiro, MD, Tadashi Yamamoto, MD, Nobu Akiyama, MD, PhD, Kazuo Kawasugi, MD, PhD, Naoki Shirafuji, MD, PhD

Blood (2011) 118 (21): 1487.

https://doi.org/10.1182/blood.V118.21.1487.1487

Published: 2011

Journal Articles

Increased Levels of Histone In Human Plasma In Septic Patients with DIC.

Kazuo Kawasugi, Tadashi Yamamoto, Ryosuke Shirasaki, Haruko Tashiro, Naoki Shirafuji

Blood (2010) 116 (21): 1422.

https://doi.org/10.1182/blood.V116.21.1422.1422

Published: 2010

Journal Articles

Chronic Myelogenous Leukemia Cells Contribute to a Bone Marrow-Stroma in In Vivo NOD/SCID Mouse System.

Ryosuke Shirasaki, Haruko Tashiro, Yoko Oka, Toshihiko Sugao, Nobu Akiyama, Kazuo Kawasugi, Naoki Shirafuji

Blood (2009) 114 (22): 2191.

https://doi.org/10.1182/blood.V114.22.2191.2191

Published: 2009

Journal Articles

Acute Myelogenous Leukemia Blasts Contribute to a Bone Marrow-Stroma in In Vivo NOD/SCID Mouse System..

Haruko Tashiro, Ryosuke Shirasaki, Yoko Oka, Toshihiko Sugao, Nobu Akiyama, Kazuo Kawasugi, Naoki Shirafuji

Blood (2009) 114 (22): 1621.

https://doi.org/10.1182/blood.V114.22.1621.1621

Published: 2009

NARROW

Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1 / FLT3 -ITD Genotypes in Patients with Acute Myeloid Leukemia

LigandCD70.CAR As a Platform for Dual-Targeting CAR T Cells for Acute Myeloid Leukemia

A Phase I/II Clinical Trial of Piggybac -Modified GMR CAR-T Cell Therapy for CD116 Positive Relapsed/Refractory Myeloid Malignancies

Mutated GM-CSF-Based CAR T-Cells Targeting CD116/CD131 Complexes Exhibit Enhanced Anti-Tumor Effects Against Acute Myeloid Leukemia

Enhancing the Effect of CLL-1 CAR T Cells with Interleukin-15 for Treatment of Acute Myeloid Leukemia

Interleukin (IL)-1 Beta and IL-6 Activated Acute and Chronic Myelogenous Leukemia-Derived Myofibroblasts to Express Leukemia-Specific Transcripts

FLT3-ITD Mutation in MDS Patients Is Associated with Early Transformation to AML

Low High-Density Lipoprotein Cholesterol (HDL) Is a Significant Poor Prognostic Factor in Malignant Lymphoma

Chimeric Antigen Receptor (CAR) T Cell Therapy for CD7-Positive Acute Myeloid Leukemia

CD7 CAR for the Treatment of Acute Myeloid and Lymphoid Leukemia

A T-cell–directed chimeric antigen receptor for the selective treatment of T-cell malignancies

T Cell Receptor Vbeta Repertoire Plays An Important Role In Graft-Versus-Leukemia Effect To Acute Lymphocytic Leukemia With TCF3-PBX1

Interleukin-1 Beta Promotes the Expression of Prox-1 and Vascular Endothelial Growth Factor Receptor Type-3 in Adult Human Dermal Fibroblasts

CD56(+)CD146(+) Cells in Normal Human Bone Marrow-Stroma Proliferated to Form Tumors in severe Combined Immunodeficiency Mice

Increased Levels of PTX3 in Human Plasma in Septic Patients with DIC

Interleukin-1β Promotes the Expression of CD34 and Granulocyte Colony-Stimulating Factor-Receptor in Adult Dermal Fibroblasts

Tcf3/Pbx1 Fusion Molecule Induces the Transcription of Prox-1 and Vascular Endothelial Growth Factor Receptor Type-3

Increased Levels of Histone In Human Plasma In Septic Patients with DIC.

Chronic Myelogenous Leukemia Cells Contribute to a Bone Marrow-Stroma in In Vivo NOD/SCID Mouse System.

Acute Myelogenous Leukemia Blasts Contribute to a Bone Marrow-Stroma in In Vivo NOD/SCID Mouse System..

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only